The safety of a new therapy for an aggressive brain tumor was demonstrated in a recent clinical trial, and the drug also cleared other important hurdles.
In a new clinical exposure program, doctoral students in the Driskill Graduate Program in Life Sciences partner with clinicians at Lurie Children’s Hospital to forge connections between basic and clinical research efforts.
Northwestern Medicine scientists have identified a novel strategy that could improve the efficacy of immunotherapy in treating chronic viral infections.
According to a recent study, Northwestern scientists have pinpointed how an ectoenzyme called CD73 undermines the effectiveness of an emerging cancer therapy.
Subcutaneous fat cells in mice expanded after a gene transcription factor was deleted, according to a new study published in Cell Reports.
A one-time stem cell transplantation therapy for multiple sclerosis showed improvements over the current treatment, according to a preliminary trial.
A human protein called RBBP6 helps fight the Ebola virus by interfering with the virus replication cycle, according to a study recently published in Cell.
A study published in the journal Cell uncovers how poxviruses take control of a protein complex in order to enhance their replication and counteract an immune response in hosts.
A unique bacterial strain isolated from a patient with pelvic pain could be the key to treating prostate cancer with immunotherapy, according to a study published in Nature Communications.
A new study advances the understanding of how human cytomegalovirus replicates within cells and also reveals potential treatment targets for the common virus.